Participant flow24

How many started, completed or left each group, period by period.

1 to 20 of 24

Period	Milestone	Group	Participants
Baseline Phase	STARTED	Placebo	98
Baseline Phase	STARTED	Pregabalin 150 mg/Day	87
Baseline Phase	STARTED	Pregabalin 300 mg/Day	90
Baseline Phase	STARTED	Pregabalin 600 mg/Day	97
Baseline Phase	COMPLETED	Placebo	98
Baseline Phase	COMPLETED	Pregabalin 150 mg/Day	87
Baseline Phase	COMPLETED	Pregabalin 300 mg/Day	89
Baseline Phase	COMPLETED	Pregabalin 600 mg/Day	97
Baseline Phase	NOT COMPLETED	Placebo	0
Baseline Phase	NOT COMPLETED	Pregabalin 150 mg/Day	0
Baseline Phase	NOT COMPLETED	Pregabalin 300 mg/Day	1
Baseline Phase	NOT COMPLETED	Pregabalin 600 mg/Day	0
Double-blind Phase	STARTED	Placebo	98
Double-blind Phase	STARTED	Pregabalin 150 mg/Day	87
Double-blind Phase	STARTED	Pregabalin 300 mg/Day	89
Double-blind Phase	STARTED	Pregabalin 600 mg/Day	97
Double-blind Phase	COMPLETED	Placebo	83
Double-blind Phase	COMPLETED	Pregabalin 150 mg/Day	73
Double-blind Phase	COMPLETED	Pregabalin 300 mg/Day	71
Double-blind Phase	COMPLETED	Pregabalin 600 mg/Day	70

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00394901/flow